Protein Description

Gene Symbol PDGFRB
Entrez ID 5159
Uniprot ID P09619
Description platelet-derived growth factor receptor, beta polypeptide
Chromosomal Location chr5: 150,113,837-150,155,872
Ontology GO ID GO Term Definition Evidence

BP

GO:0000165

MAPK cascade

An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.

TAS

BP

GO:0006024

glycosaminoglycan biosynthetic process

The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

IDA

BP

GO:0007186

G-protein coupled receptor signaling pathway

A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).

IEA

BP

GO:0008284

positive regulation of cell proliferation

Any process that activates or increases the rate or extent of cell proliferation.

IMP

BP

GO:0009636

response to toxic substance

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.

IEA

BP

GO:0010863

positive regulation of phospholipase C activity

Any process that increases the rate of phospholipase C activity.

IDA

BP

GO:0014066

regulation of phosphatidylinositol 3-kinase signaling

Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.

TAS

BP

GO:0014068

positive regulation of phosphatidylinositol 3-kinase signaling

Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.

ISS

BP

GO:0014911

positive regulation of smooth muscle cell migration

Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration.

IMP|ISS

BP

GO:0016477

cell migration

The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.

IMP

BP

GO:0018108

peptidyl-tyrosine phosphorylation

The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.

IDA

BP

GO:0030335

positive regulation of cell migration

Any process that activates or increases the frequency, rate or extent of cell migration.

IDA

BP

GO:0032355

response to estradiol

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.

IEA

BP

GO:0032516

positive regulation of phosphoprotein phosphatase activity

Any process that activates or increases the activity of a phosphoprotein phosphatase.

IDA

BP

GO:0032526

response to retinoic acid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus.

IEA

BP

GO:0032956

regulation of actin cytoskeleton organization

Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.

ISS

BP

GO:0032967

positive regulation of collagen biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.

IEA

BP

GO:0034405

response to fluid shear stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.

IEA

BP

GO:0035025

positive regulation of Rho protein signal transduction

Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.

IEA

BP

GO:0035441

cell migration involved in vasculogenesis

The orderly movement of a cell from one site to another that will contribute to the differentiation of an endothelial cell that will form de novo blood vessels and tubes.

ISS

BP

GO:0035789

metanephric mesenchymal cell migration

The orderly movement of undifferentiated metanephric mesenchymal cells (precursors to metanephric mesangial cells) from the mesenchyme into the cleft of the developing glomerulus, during development of the metanephros.

IEA

BP

GO:0035791

platelet-derived growth factor receptor-beta signaling pathway

A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IMP

BP

GO:0035793

positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway

Any process that increases the frequency, rate or extent of metanephric mesenchymal cell migration as a result of the series of molecular signals generated as a consequence of a platelet-derived growth factor receptor-beta binding to one of its physiological ligands.

ISS

BP

GO:0035909

aorta morphogenesis

The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body.

ISS

BP

GO:0036120

cellular response to platelet-derived growth factor stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus.

IEA

BP

GO:0038091

positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway

A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a platelet-derived growth factor receptor (PDGFR) on the surface of a cell, which activates or increases the frequency, rate or extent of cell proliferation.

IDA

BP

GO:0042060

wound healing

The series of events that restore integrity to a damaged tissue, following an injury.

IEA

BP

GO:0042542

response to hydrogen peroxide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.

IEA

BP

GO:0043065

positive regulation of apoptotic process

Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.

IEA

BP

GO:0043066

negative regulation of apoptotic process

Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.

IEA

BP

GO:0043406

positive regulation of MAP kinase activity

Any process that activates or increases the frequency, rate or extent of MAP kinase activity.

ISS

BP

GO:0043547

positive regulation of GTPase activity

Any process that activates or increases the activity of a GTPase.

IEA

BP

GO:0043552

positive regulation of phosphatidylinositol 3-kinase activity

Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.

IDA

BP

GO:0043627

response to estrogen

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.

IEA

BP

GO:0045840

positive regulation of mitotic nuclear division

Any process that activates or increases the frequency, rate or extent of mitosis.

ISS

BP

GO:0046488

phosphatidylinositol metabolic process

The chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.

IMP

BP

GO:0046777

protein autophosphorylation

The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).

IDA

BP

GO:0046854

phosphatidylinositol phosphorylation

The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.

IEA

BP

GO:0048008

platelet-derived growth factor receptor signaling pathway

The series of molecular signals generated as a consequence of a platelet-derived growth factor receptor binding to one of its physiological ligands.

IDA

BP

GO:0048015

phosphatidylinositol-mediated signaling

A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.

IMP|TAS

BP

GO:0048146

positive regulation of fibroblast proliferation

Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

IEA

BP

GO:0048661

positive regulation of smooth muscle cell proliferation

Any process that activates or increases the rate or extent of smooth muscle cell proliferation.

IMP|ISS

BP

GO:0048839

inner ear development

The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.

IEA

BP

GO:0050921

positive regulation of chemotaxis

Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.

ISS

BP

GO:0055003

cardiac myofibril assembly

The process whose specific outcome is the progression of the cardiac myofibril over time, from its formation to the mature structure. A cardiac myofibril is a myofibril specific to cardiac muscle cells.

ISS

BP

GO:0055093

response to hyperoxia

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension.

IEA

BP

GO:0060326

cell chemotaxis

The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).

IDA

BP

GO:0060981

cell migration involved in coronary angiogenesis

The orderly movement of a cell from one site to another that will contribute to the formation of new blood vessels in the heart from pre-existing blood vessels.

ISS

BP

GO:0061298

retina vasculature development in camera-type eye

The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.

ISS

BP

GO:0070374

positive regulation of ERK1 and ERK2 cascade

Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.

IMP|ISS

BP

GO:0071670

smooth muscle cell chemotaxis

The directed movement of a smooth muscle cell in response to an external stimulus.

ISS

BP

GO:0072075

metanephric mesenchyme development

The biological process whose specific outcome is the progression of a metanephric mesenchyme from an initial condition to its mature state. This process begins with the formation of metanephric mesenchyme and ends with the mature structure. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros.

IEA

BP

GO:0072262

metanephric glomerular mesangial cell proliferation involved in metanephros development

The multiplication or reproduction of glomerular mesangial cells in the metanephros, resulting in the expansion of the population.

ISS

BP

GO:0072277

metanephric glomerular capillary formation

The process that gives rise to a metanephric glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts.

ISS

BP

GO:0072278

metanephric comma-shaped body morphogenesis

The process in which the metanephric comma-shaped body is generated and organized. The metanephric comma-shaped body is the precursor structure to the metanephric S-shaped body that contributes to the morphogenesis of a nephron in the metanephros.

IEA

BP

GO:0072284

metanephric S-shaped body morphogenesis

The process in which the metanephric S-shaped body is generated and organized. The metanephric S-shaped body is the successor of the metanephric comma-shaped body that contributes to the morphogenesis of a nephron in the metanephros.

IEA

BP

GO:0090280

positive regulation of calcium ion import

Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle.

ISS

BP

GO:2000379

positive regulation of reactive oxygen species metabolic process

Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.

ISS

BP

GO:2000491

positive regulation of hepatic stellate cell activation

Any process that activates or increases the frequency, rate or extent of hepatic stellate cell activation.

IEA

BP

GO:2000573

positive regulation of DNA biosynthetic process

Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process.

ISS

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

ISS

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

ISS

CC

GO:0005886

plasma membrane

The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

TAS

CC

GO:0005925

focal adhesion

Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.

IDA

CC

GO:0009986

cell surface

The external part of the cell wall and/or plasma membrane.

IEA

CC

GO:0016020

membrane

A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

IDA

CC

GO:0016021

integral component of membrane

The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

IEA

CC

GO:0016023

cytoplasmic, membrane-bounded vesicle

A membrane-bounded vesicle found in the cytoplasm of the cell.

IEA

CC

GO:0016324

apical plasma membrane

The region of the plasma membrane located at the apical end of the cell.

ISS

CC

GO:0031226

intrinsic component of plasma membrane

The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.

IDA

CC

GO:0043202

lysosomal lumen

The volume enclosed within the lysosomal membrane.

IEA

CC

GO:0070062

extracellular exosome

A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.

IDA

MF

GO:0004713

protein tyrosine kinase activity

Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.

IDA

MF

GO:0004992

platelet activating factor receptor activity

Combining with platelet activating factor to initiate a change in cell activity.

TAS

MF

GO:0005017

platelet-derived growth factor-activated receptor activity

Combining with platelet-derived growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.

TAS

MF

GO:0005019

platelet-derived growth factor beta-receptor activity

Combining with platelet-derived growth factor isoform PDGF-BB or PDGF-AB to initiate a change in cell activity.

IDA|IMP

MF

GO:0005088

Ras guanyl-nucleotide exchange factor activity

Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.

TAS

MF

GO:0005102

receptor binding

Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IPI

MF

GO:0005161

platelet-derived growth factor receptor binding

Interacting selectively and non-covalently with the platelet-derived growth factor receptor.

IPI

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0005524

ATP binding

Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.

IEA

MF

GO:0019899

enzyme binding

Interacting selectively and non-covalently with any enzyme.

IPI

MF

GO:0019901

protein kinase binding

Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.

IPI

MF

GO:0038085

vascular endothelial growth factor binding

Interacting selectively and non-covalently with a vascular endothelial growth factor.

IPI

MF

GO:0043548

phosphatidylinositol 3-kinase binding

Interacting selectively and non-covalently with a phosphatidylinositol 3-kinase, any enzyme that catalyzes the addition of a phosphate group to an inositol lipid at the 3' position of the inositol ring.

IEA

MF

GO:0046934

phosphatidylinositol-4,5-bisphosphate 3-kinase activity

Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).

TAS

MF

GO:0048407

platelet-derived growth factor binding

Interacting selectively and non-covalently with platelet-derived growth factor.

IDA|IPI

Domain ID Description

IPR000719

Protein kinase domain

IPR001245

Serine-threonine/tyrosine-protein kinase, catalytic domain

IPR001824

Tyrosine-protein kinase, receptor class III, conserved site

IPR003598

Immunoglobulin subtype 2

IPR003599

Immunoglobulin subtype

IPR007110

Immunoglobulin-like domain

IPR008266

Tyrosine-protein kinase, active site

IPR011009

Protein kinase-like domain

IPR013098

Immunoglobulin I-set

IPR013151

Immunoglobulin

IPR013783

Immunoglobulin-like fold

IPR016243

Tyrosine-protein kinase, CSF-1/PDGF receptor family

IPR017441

Protein kinase, ATP binding site

IPR020635

Tyrosine-protein kinase, catalytic domain

IPR027288

Platelet-derived growth factor receptor beta

Pathway ID Pathway Term Pathway Source

hsa01521

EGFR tyrosine kinase inhibitor resistance

KEGG

hsa04010

MAPK signaling pathway

KEGG

hsa04014

Ras signaling pathway

KEGG

hsa04015

Rap1 signaling pathway

KEGG

hsa04020

Calcium signaling pathway

KEGG

hsa04060

Cytokine-cytokine receptor interaction

KEGG

hsa04072

Phospholipase D signaling pathway

KEGG

hsa04151

PI3K-Akt signaling pathway

KEGG

hsa04510

Focal adhesion

KEGG

hsa04540

Gap junction

KEGG

hsa04810

Regulation of actin cytoskeleton

KEGG

hsa05166

HTLV-I infection

KEGG

hsa05200

Pathways in cancer

KEGG

hsa05206

MicroRNAs in cancer

KEGG

hsa05214

Glioma

KEGG

hsa05215

Prostate cancer

KEGG

hsa05218

Melanoma

KEGG

hsa05230

Central carbon metabolism in cancer

KEGG

hsa05231

Choline metabolism in cancer

KEGG

WP3640

Imatinib and Chronic Myeloid Leukemia

WikiPathways

WP306

Focal Adhesion

WikiPathways

WP51

Regulation of Actin Cytoskeleton

WikiPathways

WP3931

ESC Pluripotency Pathways

WikiPathways

WP2526

PDGF Pathway

WikiPathways

WP382

MAPK Signaling Pathway

WikiPathways

WP322

Osteoblast Signaling

WikiPathways

WP2261

Signaling Pathways in Glioblastoma

WikiPathways

WP3932

Focal Adhesion-PI3K-Akt-mTOR-signaling pathway

WikiPathways

UMLS CUI UMLS Term

C0004782

Basal Ganglia Diseases

C0006663

Calcinosis

C0023480

Leukemia, Myelomonocytic, Chronic

C0023893

Liver Cirrhosis, Experimental

Tissue Cell Type

skin

fibroblasts

No databases found.

Pubmed ID Author Year Title

15820804

Oksjoki et al.

2005

Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover

Gene Symbol Entrez ID Uniprot ID Score

PLCG2

5336

P16885

0.00

PRKCD

5580

Q05655

0.00

SHB

6461

Q15464

0.00

VEGFB

7423

P49765

0.00

CRKL

1399

P46109

0.49

GAB1

2549

Q13480

0.52

PIK3CA

5290

P42336

0.52

STAT5B

6777

P51692

0.52

ARAF

369

P10398

0.55

SYNGAP1

8831

Q96PV0

0.55

PRDX2

7001

P32119

0.59

PIK3R2

5296

O00459

0.62

ADRBK1

156

P25098

0.63

ATP6V0C

527

P27449

0.63

ETV6

2120

P41212

0.63

IRF8

3394

Q02556

0.63

MFGE8

4240

Q08431

0.63

TRIP6

7205

Q15654

0.63

SOCS1

8651

O15524

0.63

LAPTM4B

55353

Q86VI4

0.63

KLHL12

59349

Q53G59

0.63

TYK2

7297

P29597

0.65

STAT1

6772

P42224

0.66

PIK3R3

8503

Q92569

0.66

PIK3C2B

5287

O00750

0.67

PTPRC

5788

P08575

0.68

PTPRK

5796

Q15262

0.68

PTPRO

5800

Q16827

0.68

SH2B2

10603

O14492

0.68

STAT5A

6776

P42229

0.70

GRB7

2886

Q14451

0.71

MYO1E

4643

Q12965

0.72

PDGFA

5154

P04085

0.72

BCLAF1

9774

Q9NYF8

0.72

ZZEF1

23140

O43149

0.72

FGD6

55785

Q6ZV73

0.72

FOXK1

221937

P85037

0.72

KRTAP4-12

83755

Q9BQ66

0.73

FYN

2534

P06241

0.81

EGFR

1956

P00533

0.83

SLA

6503

Q13239

0.84

RAF1

5894

P04049

0.86

SRC

6714

P12931

0.87

PTPN12

5782

Q05209

0.88

RASA1

5921

P20936

0.88

CRK

1398

P46108

0.89

GRB2

2885

P62993

0.90

PIK3R1

5295

P27986

0.90

PDGFRB

5159

P09619

0.96

PLCG1

5335

P19174

0.96

EPHB1

2047

P54762

0.00

FER

2241

P16591

0.00

FGF1

2246

P05230

0.00

FGF2

2247

P09038

0.00

FGF7

2252

P21781

0.00

FGF13

2258

Q92913

0.00

HCK

3055

P08631

0.00

HGF

3082

P14210

0.00

IGF1

3479

P05019

0.00

KRAS

3845

P01116

0.00

LCK

3932

P06239

0.00

LRP6

4040

O75581

0.00

MYC

4609

P01106

0.00

ARHGEF7

8874

Q14155

0.00

BCAR1

9564

P56945

0.00

PDGFC

56034

Q9NRA1

0.00

HSP90AB1

3326

P08238

0.49

PDGFD

80310

Q9GZP0

0.52

NEDD4

4734

P46934

0.59

BAG1

573

Q99933

0.62

YES1

7525

P07947

0.62

PDAP1

11333

Q13442

0.62

COPB1

1315

P53618

0.63

HSP90AA1

3320

P07900

0.63

NTRK1

4914

P04629

0.63

VEGFA

7422

P15692

0.63

PDCD6IP

10015

Q8WUM4

0.63

ERRFI1

54206

Q9UJM3

0.63

JAK1

3716

P23458

0.65

JAK2

3717

O60674

0.65

PTPN2

5771

P17706

0.65

STAT3

6774

P40763

0.65

PTK2

5747

Q05397

0.66

PTPRB

5787

P23467

0.68

PTPRE

5791

P23469

0.68

PTPRG

5793

P23470

0.68

PTPRR

5801

Q15256

0.68

PTPN22

26191

Q9Y2R2

0.68

GRB10

2887

Q13322

0.69

SLC9A3R2

9351

Q15599

0.70

VAV2

7410

P52735

0.72

VAV3

10451

Q9UKW4

0.72

EIF2AK2

5610

P19525

0.73

SNX4

8723

O95219

0.73

COPA

1314

P53621

0.74

ITGB3

3690

P05106

0.74

CAV3

859

P56539

0.75

CBL

867

P22681

0.75

PTPN6

5777

P29350

0.75

TNK2

10188

Q07912

0.75

GRB14

2888

Q14449

0.76

SNX2

6643

O60749

0.77

CAV1

857

Q03135

0.79

VAV1

7409

P15498

0.82

SH3KBP1

30011

Q96B97

0.82

S1PR1

1901

P21453

0.83

SHC1

6464

P29353

0.84

NCK1

4690

P16333

0.87

PTEN

5728

P60484

0.87

PTPRJ

5795

Q12913

0.87

SNX1

6642

Q13596

0.87

PDGFB

5155

P01127

0.90

PDGFRA

5156

P16234

0.90

NCK2

8440

O43639

0.90

SLC9A3R1

9368

O14745

0.97

PTPN1

5770

P18031

0.98

PTPN11

5781

Q06124

0.99